Catalyst Wire Dossier Catalyst Wire Dossier

Universal Donor CD33 CAR Natural Killer Cells

CD33 CAR NK cells · Nationwide Children's Hospital
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Universal Donor CD33 CAR Natural Killer Cells, covering 2025-11-12 to 2025-11-12. Get the full timeline:

Most recent: Clinical Trial Update: Phase I/II Clinical Trial of Universal Donor CD33 CAR Natural Killer Cells for AML [Phase 1, Phase 2]

See pricing